ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus

By Rimmelzwaan G.F.   Claas E.C.J.   Van Amerongen G.   de Jong J.C.   Osterhaus A.D.M.E.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1355-1358

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

By De Donato S.   Granoff D.   Minutello M.   Lecchi G.   Faccini M.   Agnello M.   Senatore F.   Verweij P.   Fritzell B.   Podda A.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3094-3101

Elsevier

Access to resources Recommend Favorite

Human influenza virus A/HongKong/156/97 (H5N1) infection

By Claas E.C.J.   de Jong J.C.   van Beek R.   Rimmelzwaan G.F.   Osterhaus A.D.M.E.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 977-978

Elsevier

Access to resources Recommend Favorite

Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy

By Iorio A.M.   Francisci D.   Camilloni B.   Stagni G.   De Martino M.   Toneatto D.   Bugarini R.   Neri M.   Podda A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3629-3637

Elsevier

Access to resources Recommend Favorite

Genomic Analysis of Influenza A Viruses, including Avian Flu (H5N1) Strains

By Ahn Insung   Jeong Byeong-Jin   Bae Se-Eun   Jung Jin   Son Hyeon  

European Journal of Epidemiology, Vol. 21, Iss. 7, 2006-07 ,pp. : 511-519

Springer Publishing Company

Access to resources Recommend Favorite